Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
gene therapy
5
×
life sciences
national
national blog main
national top stories
new york top stories
5
×
san francisco top stories
biogen
clinical trials
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
drug prices
glaxosmithkline
indiana blog main
indiana top stories
merck
novartis
roche
abbvie
adverum biotechnologies
alzheimer's disease
amgen
What
drug
5
×
bio
roundup
patients
fda
new
news
road
therapy
acquisitions
advanced
albert
approval
approved
aren’t
arrival
atrophy
award
biggest
biogen’s
biopharmaceutical
bourla
cancer
ceo
companies
company
convo
crispr
daily
data
death
decades
dems
developers
drugs
earlier
evrysdi
failures
friday
future
Language
unset
unknown
Current search:
drug
×
" gene therapy "
×
" new york top stories "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More